These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 23743065)

  • 1. Platelet-activating factor receptor knockout mice are protected from MPTP-induced dopaminergic degeneration.
    Kim BK; Shin EJ; Kim HC; Chung YH; Dang DK; Jung BD; Park DH; Wie MB; Kim WK; Shimizu T; Nabeshima T; Jeong JH
    Neurochem Int; 2013 Sep; 63(3):121-32. PubMed ID: 23743065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of platelet-activating factor receptor attenuates abnormal behaviors induced by phencyclidine in mice through down-regulation of NF-κB.
    Tran TV; Park SJ; Shin EJ; Tran HQ; Jeong JH; Jang CG; Lee YJ; Nah SY; Nabeshima T; Kim HC
    Brain Res Bull; 2018 Mar; 137():71-78. PubMed ID: 29122692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deficiency of TNF receptors suppresses microglial activation and alters the susceptibility of brain regions to MPTP-induced neurotoxicity: role of TNF-alpha.
    Sriram K; Matheson JM; Benkovic SA; Miller DB; Luster MI; O'Callaghan JP
    FASEB J; 2006 Apr; 20(6):670-82. PubMed ID: 16581975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine receptor D3 expressed on CD4+ T cells favors neurodegeneration of dopaminergic neurons during Parkinson's disease.
    González H; Contreras F; Prado C; Elgueta D; Franz D; Bernales S; Pacheco R
    J Immunol; 2013 May; 190(10):5048-56. PubMed ID: 23589621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of nuclear transcription factor kappa B (NF-kappaB) for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahyropyridine)-induced apoptosis in nigral neurons of mice.
    Aoki E; Yano R; Yokoyama H; Kato H; Araki T
    Exp Mol Pathol; 2009 Feb; 86(1):57-64. PubMed ID: 19027004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SEA0400, a specific Na+/Ca2+ exchange inhibitor, prevents dopaminergic neurotoxicity in an MPTP mouse model of Parkinson's disease.
    Ago Y; Kawasaki T; Nashida T; Ota Y; Cong Y; Kitamoto M; Takahashi T; Takuma K; Matsuda T
    Neuropharmacology; 2011 Dec; 61(8):1441-51. PubMed ID: 21903118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of p38 pathway-dependent MPTP-induced dopaminergic neurodegeneration in estrogen receptor alpha knockout mice.
    Hwang CJ; Choi DY; Jung YY; Lee YJ; Yun JS; Oh KW; Han SB; Oh S; Park MH; Hong JT
    Horm Behav; 2016 Apr; 80():19-29. PubMed ID: 26836768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-18 null mice show diminished microglial activation and reduced dopaminergic neuron loss following acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment.
    Sugama S; Wirz SA; Barr AM; Conti B; Bartfai T; Shibasaki T
    Neuroscience; 2004; 128(2):451-8. PubMed ID: 15350655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical role of microglial NADPH oxidase-derived free radicals in the in vitro MPTP model of Parkinson's disease.
    Gao HM; Liu B; Zhang W; Hong JS
    FASEB J; 2003 Oct; 17(13):1954-6. PubMed ID: 12897068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of angiotensin-converting enzyme inhibitor perindopril on interneurons in MPTP-treated mice.
    Kurosaki R; Muramatsu Y; Kato H; Watanabe Y; Imai Y; Itoyama Y; Araki T
    Eur Neuropsychopharmacol; 2005 Jan; 15(1):57-67. PubMed ID: 15572274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor-alpha.
    Sriram K; Miller DB; O'Callaghan JP
    J Neurochem; 2006 Feb; 96(3):706-18. PubMed ID: 16405514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mice deficient in TNF receptors are protected against dopaminergic neurotoxicity: implications for Parkinson's disease.
    Sriram K; Matheson JM; Benkovic SA; Miller DB; Luster MI; O'Callaghan JP
    FASEB J; 2002 Sep; 16(11):1474-6. PubMed ID: 12205053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemokines in the MPTP model of Parkinson's disease: absence of CCL2 and its receptor CCR2 does not protect against striatal neurodegeneration.
    Kalkonde YV; Morgan WW; Sigala J; Maffi SK; Condello C; Kuziel W; Ahuja SS; Ahuja SK
    Brain Res; 2007 Jan; 1128(1):1-11. PubMed ID: 17126305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of p38 MAPK in the substantia nigra leads to nuclear translocation of NF-kappaB in MPTP-treated mice: implication in Parkinson's disease.
    Karunakaran S; Ravindranath V
    J Neurochem; 2009 Jun; 109(6):1791-9. PubMed ID: 19457134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of blocking the dopamine biosynthesis and of neurotoxic dopamine depletion with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on voluntary wheel running in mice.
    Leng A; Mura A; Hengerer B; Feldon J; Ferger B
    Behav Brain Res; 2004 Oct; 154(2):375-83. PubMed ID: 15313025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranasal PRGF-Endoret enhances neuronal survival and attenuates NF-κB-dependent inflammation process in a mouse model of Parkinson's disease.
    Anitua E; Pascual C; Pérez-Gonzalez R; Orive G; Carro E
    J Control Release; 2015 Apr; 203():170-80. PubMed ID: 25702964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet activating factor-induced neuronal apoptosis is initiated independently of its G-protein coupled PAF receptor and is inhibited by the benzoate orsellinic acid.
    Ryan SD; Harris CS; Mo F; Lee H; Hou ST; Bazan NG; Haddad PS; Arnason JT; Bennett SA
    J Neurochem; 2007 Oct; 103(1):88-97. PubMed ID: 17877634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calycosin attenuates MPTP-induced Parkinson's disease by suppressing the activation of TLR/NF-κB and MAPK pathways.
    Yang J; Jia M; Zhang X; Wang P
    Phytother Res; 2019 Feb; 33(2):309-318. PubMed ID: 30421460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-Methyl, N-propynyl-2-phenylethylamine (MPPE), a Selegiline Analog, Attenuates MPTP-induced Dopaminergic Toxicity with Guaranteed Behavioral Safety: Involvement of Inhibitions of Mitochondrial Oxidative Burdens and p53 Gene-elicited Pro-apoptotic Change.
    Shin EJ; Nam Y; Lee JW; Nguyen PT; Yoo JE; Tran TV; Jeong JH; Jang CG; Oh YJ; Youdim MBH; Lee PH; Nabeshima T; Kim HC
    Mol Neurobiol; 2016 Nov; 53(9):6251-6269. PubMed ID: 26563498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuronal or inducible nitric oxide synthase (NOS) expression level is not involved in the different susceptibility to nigro-striatal dopaminergic neurotoxicity induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) between C57BL/6 and BALB/c mice.
    Ito T; Uchida K; Nakayama H
    Exp Toxicol Pathol; 2013 Jan; 65(1-2):121-5. PubMed ID: 21788124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.